CDXS Codexis appoints Peter Strumph as interim Chief Executive Officer (4.58 -0.07)
Co announced that effective immediately, the Board of Directors has appointed Peter Strumph as the company's interim Chief Executive Officer. Alan Shaw, Ph.D. has resigned as President and Chief Executive Officer and from the Board of Directors to pursue other interests. Mr. Strumph was the Senior Vice President and Business Head of Pharmaceuticals. 16:05